Radiation Esophagitis Mimicking Disease Progression on FAPI PET/CT: Time to Re-evaluate FAPI in Response Evaluation?
Indian Journal of Nuclear Medicine · 17.11.2026 · 1-3
DOI: 10.25259/ijnm_131_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 17.11.2026. Verfasst von Suraj Kumar und 4 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
68 Ga- Fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) is increasingly used in oesophageal cancer staging and response assessment. However, radiation-induced inflammatory changes can cause false-positive tracer uptake, mimicking disease progression. We report a case of post-chemoradiotherapy radiation esophagitis resulting in diffuse oesophageal FAPI uptake with discordant CT findings. This case highlights the importance of correlating tracer uptake with structural CT findings and clinical context.
Zitieren
APA
Kumar, S., Shankaramurthy, G., Nayak, S. P., Babu, S. M., & Vishnu, N. T. (2026). Radiation Esophagitis Mimicking Disease Progression on FAPI PET/CT: Time to Re-evaluate FAPI in Response Evaluation?. Indian Journal of Nuclear Medicine, 0, 1-3. https://doi.org/10.25259/ijnm_131_2026
Vancouver
Kumar S, Shankaramurthy G, Nayak SP, Babu SM, Vishnu NT. Radiation Esophagitis Mimicking Disease Progression on FAPI PET/CT: Time to Re-evaluate FAPI in Response Evaluation?. Indian Journal of Nuclear Medicine. 2026;0:1-3. doi:10.25259/ijnm_131_2026
BibTeX
@article{Kumar2026,
author = {Kumar, Suraj and Shankaramurthy, Gayana and Nayak, Sandeep P and Babu, Suresh MC and Vishnu, Nisha T},
title = {Radiation Esophagitis Mimicking Disease Progression on FAPI PET/CT: Time to Re-evaluate FAPI in Response Evaluation?},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {0},
pages = {1--3},
doi = {10.25259/ijnm_131_2026}
}
EUVIMED